Keiko Kan-O Japan

Current Position

Lecturer, Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan (since November 2025)

Address: 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan

Email: kano.keiko@twmu.ac.jp

Education

YearDegree / Qualification
2012PhD (Medicine), Kyushu University Graduate School of Medical Sciences
2002Medical Licence, Japan
2002MD, Kyushu University School of Medicine

Professional Appointments

PeriodPosition
2025–presentLecturer, Department of Respiratory Medicine, Tokyo Women's Medical University
2024–2025Assistant Professor, Department of Respiratory Medicine, Tokyo Women's Medical University
2022–2024Assistant Professor, Department of Respiratory Medicine, Kyushu University Hospital
2017–2022Medical Staff, Respiratory Medicine and Endoscopy, Kyushu University Hospital
2014–2017Postdoctoral Fellow, Monash Institute of Medical Research, Melbourne, Australia (Prof. Philip G. Bardin)
2012–2014Staff Physician, Respiratory Medicine, Nishi-Fukuoka Hospital
2002–2006Residency and clinical training in internal and respiratory medicine, Fukuoka and Kitakyushu

Editorial, International and Society Roles

  • Editor-in-Chief, Respirology Case Reports (2022–present; second term)
  • Deputy Editor-in-Chief, Respirology (2024–2025); Deputy Editor, Asthma, Respirology (2021–2022)
  • Councillor and Fellow (FAPSR), Asian Pacific Society of Respirology (2024–present)
  • Delegate and committee member (international, education, public relations, guideline management), Japanese Respiratory Society
  • Delegate and committee member (international exchange, public relations, work-style reform), Japanese Society of Allergology
  • Delegate and Guideline Committee member, Japanese Society of Asthma
  • Guideline author: JRS COPD Guidelines (6th and 7th editions, systematic review), JRS Severe Asthma Handbook (3rd edition), JSA Asthma Practice Guidelines 2026
  • Next-Generation Task Force (ENGAGE-TF), Japan's 10-Year Strategy for Immune and Allergic Disease Research (2019–present)
  • Member: ATS, ERS, APSR

Board Certifications

  • Board-Certified Specialist and Supervising Physician, Japanese Respiratory Society
  • Board-Certified Specialist and Supervising Physician, Japanese Society of Allergology
  • Board-Certified Fellow and Supervising Physician, Japanese Society of Internal Medicine
  • Board-Certified Bronchoscopist, Japan Society for Respiratory Endoscopy

Research Interests

Severe asthma and COPD; biologic therapy and clinical remission; airway epithelial barrier dysfunction and epigenetics; respiratory virus infection; the oral–lung microbiome axis. h-index 20 (Scopus).

Selected Awards

YearAward
2026Allergology International Outstanding Reviewer 2025
2025Excellence Award, 65th Annual Meeting of the Japanese Respiratory Society
2023APSR Clean Air Congress Abstract Award
2022Japanese Respiratory Society Award for Women Researchers
2020APSR Assembly Virtual Meeting, Asthma Assembly Gold Award
2016Alveoli Award, Lung and Sleep Institute, Monash Medical Centre

Selected Publications

*Co-first authors.

  1. Kageyama S*, Kan-o K*, Asakawa M, et al. Enrichment of oral anaerobic bacteria in the lung microbiota of individuals with normal lung function. ISME Host Microbe. 2026 (in press).
  2. Jo A*, Kan-o K*, Ishii Y, et al. Early versus delayed dupilumab differentially restores IL-13–induced airway barrier dysfunction. Allergol Int. 2026 (in press). doi:10.1016/j.alit.2026.07.003
  3. Kan-o K, Watanabe H, Chibana K, et al. One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study. J Allergy Clin Immunol. 2026 Sep;158(3):834–844.
  4. Shiota A*, Kan-o K*, Ishii Y, et al. Epigenetic dysregulation of the NKX2-1/SPDEF axis drives persistent goblet cell differentiation and epithelial barrier dysfunction in chronic obstructive pulmonary disease. Respirology. 2026;31(5):484–497.
  5. Washio Y, Sakata S, Fukuyama S, et al. Risks of mortality and airflow limitation in Japanese with preserved ratio impaired spirometry. Am J Respir Crit Care Med. 2022;206(5):563–572.
  6. Kan-o K, Washio Y, Fujimoto T, et al. Differences in the spectrum of respiratory viruses and detection of human rhinovirus C in exacerbations of adult asthma and chronic obstructive pulmonary disease. Respir Investig. 2022;60(1):129–136.
  7. Yamamoto N, Kan-o K, Tatsuta M, et al. Incense smoke-induced oxidative stress disrupts tight junctions and bronchial epithelial barrier integrity and induces airway hyperresponsiveness in mouse lungs. Sci Rep. 2021;11(1):7222.
  8. Ogawa T, Kan-o K, Shiota A, et al. Inhibition of PI3Kδ differentially regulates poly I:C- and human metapneumovirus-induced PD-L1 and PD-L2 expression in human bronchial epithelial cells. Front Immunol. 2021;12:767666.
  9. Fujita A*, Kan-o K*, Tonai K, et al. Inhibition of PI3Kδ enhances poly I:C-induced antiviral responses and inhibits replication of human metapneumovirus in murine lungs and human bronchial epithelial cells. Front Immunol. 2020;11:432.
  10. Tatsuta M, Kan-o K, Ishii Y, et al. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37. Respir Res. 2019;20(1):251.
  11. Kan-o K, Ramirez R, MacDonald MI, et al. Human metapneumovirus infection in chronic obstructive pulmonary disease: impact of glucocorticosteroids and interferon. J Infect Dis. 2017;215(10):1536–1545.
Job Title
Lecturer
Faculty / Department / Division
Department of Respiratory Medicine
Institution / Organisation
Tokyo Women's Medical University

21 November 2026, Saturday

Time Session
12:30
13:30
Sponsored by AstraZeneca
Azza Omar Chairperson Malaysia
Ballroom 2, Lower Ground Floor

22 November 2026, Sunday

Time Session
11:00
12:00
David Lam Chi-Leung Chairperson Hong Kong
Toshiaki Kikuchi Chairperson Japan
  • Toshiaki Kikuchi Speaker Japan
    Publishing in Respirology: What are the Editors Looking For? Toshiaki Kikuchi, MD, PhD Niigata University Medical & Dental Hospital, Japan This presentation provides an overview of recent developments at Respirology, including changes in editorial leadership and the expansion of the editorial team to accommodate a growing number of manuscript submissions. Throughout these changes, the journal has maintained consistent editorial standards. The role of initial editorial screening in ensuring an efficient and rigorous peer review process will also be discussed. Particular emphasis will be placed on five key criteria that editors consider when evaluating manuscripts: novelty, methodological rigour, clinical relevance, generalisability, and relevance to a broad readership. Successful manuscripts should provide meaningful advances beyond existing knowledge, employ robust study designs with appropriate control for confounding, and demonstrate clear clinical or translational implications. Findings should also be applicable across diverse clinical settings and countries, rather than limited to highly specific local circumstances. Importantly, manuscripts should address questions of interest to a broad international respiratory readership. The presentation will also highlight Respirology’s recent impact factor trends and its commitment to publishing high-quality research of interest to a wide range of respiratory clinicians across the Asia-Pacific region and beyond. By clarifying editorial expectations, this session aims to help researchers prepare stronger manuscripts and to encourage their active participation in the peer review process. Keywords: Editorial process, Peer review, Editorial policies Disclosure Statement: The presenting author has received honoraria or consultation fees from Insmed, KYORIN Pharmaceutical, and Janssen Pharmaceutical.
  • Keiko Kan-O Speaker Japan
  • Alison Bell Speaker Australia
  • Q&A
Ballroom 1, Lower Ground Floor